#100000
I'm a partner in <a href=" http://www.cafsowrag4development.org/proof-read-essays-online/#motley ">essay for college admission</a> Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group(TM), with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that Diagnoplex has secured 1.3 million Swiss francs from a financing round led by Debiopharm.
Submitted by Anonymous (not verified) on Sun, 10/26/2014 - 09:57 to Customer Service |
